References of "Dogné, J.-M"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailDynamics of spontaneous ventricular fibrillation in acutely ischemic pigs
Desaive, Thomas ULg; Janssen, Nathalie ULg; Péters, F. et al

in Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology (2006), 8 (supplement 1)

Detailed reference viewed: 66 (40 ULg)
Full Text
Peer Reviewed
See detailFirst and second generations of COX-2 selective inhibitors
De leval, X.; Julémont, F.; Benoit, V. et al

in Mini Reviews in Medicinal Chemistry (2004), 4

Detailed reference viewed: 25 (4 ULg)
Full Text
Peer Reviewed
See detailProgress in the field of GPIIb/IIIa antagonists
Hanson, Julien ULg; De Leval, X.; David, Jean-Louis ULg et al

in Current Medicinal Chemistry - Cardiovascular and Hematological Agents (2004), 2

Detailed reference viewed: 17 (1 ULg)
Full Text
Peer Reviewed
See detailDesign, synthesis and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors
Julémont, F.; de Leval, X.; Michaux, C. et al

in Journal of Medicinal Chemistry (2004), 47

Detailed reference viewed: 14 (2 ULg)
Full Text
Peer Reviewed
See detailIdentification of COX-2 selective inhibitor
Michaux, C.; Julémont, F.; de Leval, X. et al

in Fundamental & Clinical Pharmacology (2004)

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailRecent development in the field of dual COX / 5-LOX inhibitors
Julémont, F.; Dogné, J.-M.; Pirotte, Bernard ULg et al

in Mini Reviews in Medicinal Chemistry (2004), 4

Detailed reference viewed: 9 (1 ULg)
Full Text
Peer Reviewed
See detailRecent developments in 5-lipoxygenase inhibitors
Julémont, F.; Dogné, J.-M.; Laeckmann, D. et al

in Expert Opinion on Therapeutic Patents (2003), 13

Detailed reference viewed: 7 (2 ULg)
Full Text
Peer Reviewed
See detailPharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation
De Leval, X.; Benoit, V.; Delarge, J. et al

in Prostaglandins, Leukotrienes, and Essential Fatty Acids (2003)

Detailed reference viewed: 12 (3 ULg)
Full Text
Peer Reviewed
See detailSpectral and crystallographic study of pyridinic analogues of nimesulide : determination of the active form of methanesulfonamides as COX-2 selective inhibitors
Julémont, F.; de Leval, X.; Michaux, C. et al

in Journal of Medicinal Chemistry (2002), 45

Detailed reference viewed: 19 (9 ULg)
Full Text
Peer Reviewed
See detailAdvances in the field of COX-2 inhibition
De Leval, X.; Julémont, F.; Delarge, J. et al

in Expert Opinion on Therapeutic Patents (2002), 12

Detailed reference viewed: 4 (1 ULg)
Full Text
Peer Reviewed
See detailNew trends in dual 5-LOX/COX inhibition
De Leval, X.; Julémont, F.; Delarge, J. et al

in Current Medicinal Chemistry (2002), 9

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailN-(3-Phenoxy-4-pyridinio)methanesulfonamidate
Michaux, C.; Charlier, C.; Julémont, F. et al

in Acta Crystallographica (2002)

Detailed reference viewed: 12 (4 ULg)
Full Text
Peer Reviewed
See detailEvaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood
De Leval, X.; Delarge, J.; Devel, P. et al

in Prostaglandins, Leukotrienes, and Essential Fatty Acids (2001), 64

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailRecent advances in inducible cyclooxygenase (COX-2) inhibition
De Leval, X.; Delarge, J.; Somers, F. et al

in Current Medicinal Chemistry (2000), 7(10), 1041-1062

Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biologically active substances that are involved in several physiological processes but also in pathological conditions such as ... [more ▼]

Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biologically active substances that are involved in several physiological processes but also in pathological conditions such as inflammation. Since ten years now, it is well known that this enzyme exists under two forms: a constitutive (COX-1) and an inducible form (COX-2). Both enzymes are sensitive to inhibition by conventional nonsteroidal anti-inflammatory drugs (NSAIDs). Observations that COX-1, involved in several homeostatic processes, played a housekeeping role while COX-2 expression was associated with inflammation and other pathologies such as cancer proliferation have led to the development of COX-2 selective inhibitors in order to reduce the classical side-effects, of which gastric irritation is the most common, associated with the use of conventional NSAIDs. [less ▲]

Detailed reference viewed: 17 (3 ULg)
Peer Reviewed
See detailSynthesis and evaluation of non-carboxylic pyridinic derivatives as cyclooxygenase inhibitors
Dogne, J.-M.; De Leval, X.; Delarge, J. et al

in Mediators of Inflammation (2000), 9

Detailed reference viewed: 10 (1 ULg)
Peer Reviewed
See detailProfile of nimesulide and nimesulide-L-lysine-β-cyclodextrin on chondrocyte metabolism
De Leval, X.; Dogne, J.-M.; Masereel, B. et al

in Fundamental & Clinical Pharmacology (2000), 14

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailComparison of the effects of nimesulide and nimesulide-L-lysine on PGE2 production by COX-1 and COX-2 and on chondrocyte metabolism in vitro
De Leval, X.; Henrotin, Y.; Labasse, A. et al

in Pharmacy and Pharmacology Communications (2000), 6

Detailed reference viewed: 2 (2 ULg)
Peer Reviewed
See detail7-Substituted alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as new analogues of diazoxide: effects on the insulin releasing process in vitro
Boverie, S.; Somers, F.; Ouedraogo, R. et al

in Fundamental & Clinical Pharmacology (2000), 14

Detailed reference viewed: 6 (2 ULg)
Peer Reviewed
See detailEvaluation of classical NSAIDs on COX-1 and COX-2 purified enzymes and prognosis of their effects on physiological responses
De Leval, X.; Henrotin, Y.; Masereel, B. et al

in Fundamental & Clinical Pharmacology (2000), 14

Detailed reference viewed: 2 (0 ULg)
Full Text
Peer Reviewed
See detailSynthesis and biological effects of new 3-alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides on insulin-secreting cells
Somers, F.; De Tullio, Pascal ULg; Boverie, S. et al

in Pharmacy and Pharmacology Communications (2000), 6

Detailed reference viewed: 6 (0 ULg)